How Should DCIS Be Treated?
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding...
Tag: Breast cancer
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
In a Los Angeles Times op-ed, Cynthia Ryan, a two-time breast cancer survivor, past participant in the AACR Scientist↔Survivor...